Parallel Proof of Concept Phase 2 Study of Nivolumab and Metformin Combination Treatment in Advanced Non-small Cell Lung Cancer With and Without Prior Treatment With PD-1/PD-L1 Inhibitors
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Metformin (Primary) ; Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Proof of concept; Therapeutic Use
- 15 Oct 2017 Status changed from not yet recruiting to recruiting, according to trial design presented at 18th World Conference on Lung Cancer.
- 15 Oct 2017 Trial design presented at 18th World Conference on Lung Cancer.
- 14 Feb 2017 New trial record